Neointima Formation in Injured Hamster Carotid Artery Is Effectively Prevented by the Combination G4120 and Quinapril

Summary

The prevention of neointima formation by the tissue selective angiotensin converting enzyme (ACE) inhibitor quinapril and by the combination quinapril/G4120 (a platelet α_IIbβ₃ and smooth muscle cell α_vβ₃ antagonist) was investigated in a hamster carotid artery injury model. Quinapril at 10 mg/kg/day reduced neointima formation by about 45%, 1 and 2 weeks after injury to the artery, i.e. significantly better than the non-tissue selective ACE inhibitor captopril at 100 mg/kg/day. Quinapril did not decrease the early smooth muscle cell (SMC) proliferation in the media, but in agreement with its inhibition of the carotid artery ACE activity by 62%, SMC proliferation was reduced by 70% in the newly forming intima. To improve the inhibition of early medial SMC proliferation, quinapril (10 mg/kg/day) was complemented with G4120 (100 Μg/kg/h). This combined treatment reduced the proliferation of medial SMCs to about 50% throughout the first week following injury, whereas intima SMC proliferation was reduced by 70% throughout treatment. Accordingly, the drug combination reduced neointima formation more potently than each drug separately by 70%. The disruption of medial elastic laminae, observed in the control and G4120 treated group, was consistently reduced when G4120 was complemented with quinapril. Thus, the present study shows in a hamster model of carotid artery injury, that combining drugs that prevent SMC migration and proliferation via different modes of action can lead to the effective prevention of neointima formation.

• References

• 1 Popma J, Califf RM, Topol EJ. Clinical trials of restenosis after coronary angioplasty. Circulation 1991; 84: 1426-1436
• 2 Daeman MJAP, Lombardi DM, Bosman FT, Schwartz SM. Angiotensin II induces smooth muscle cell proliferation in the normal and injured rat arterial wall. Circ Res 1991; 68: 450-456
• 3 Osterrieder W, Muller RKM, Powell JS, Clozel JP, Hefti F, Baumgartner HR. Role of angiotensin II in injury-induced neointima formation in rats. Hypertension 1993; (Suppl. 02) 60-64
• 4 Rakugi H, Kim DK, Krieger JE, Wang DS, Dzau VJ, Pratt RE. Induction of angiotensin converting enzyme in the neointima after vascular injury. J Clin Invest 1994; 93: 339-346
• 5 Naftilan AJ, Pratt RE, Dzau VJ. Induction of platelet-derived growth factor A chain and c-myc gene expression by angiotensin II in cultured rat vascular smooth mucle cells. J Clin Invest 1989; 83: 1419-1424
• 6 Gibbons GH, Pratt RE, Dzau VJ. Vascular smooth muscle cell hypertrophy vs. hyperplasia: autocrine transforming growth factor-beta 1 expression determines growth response to angiotensin II. J Clin Invest 1992; 90: 456-461
• 7 Itoh H, Mukoyama M, Pratt RE, Gibbons GH, Dzau VJ. Multiple autocrine growth factors modulate vascular smooth muscle cell growth response to angiotensin II. J Clin Invest 1993; 91: 2268-2274
• 8 Osterrieder W, Muller RKM, Powell JS, Clozel JP, Hefti F, Baumgartner HR. Role of angiotensin II in injury-induced neointima formation in rats. Hypertension 1991; 4 (Suppl. 02) II-60-II-4
• 9 Johnston Cl, Fabris B, Yamada H, Mendelsohn FAO, Cubela R, Sivell D, Jackson B. Comparative studies of tissue inhibition by angiotensin converting enzyme inhibitors. J Hypertens 1989; 7: 511-516
• 10 Rakugi H, Wang DS, Dzau VJ, Pratt RE. Potential importance of tissue angiotensin-converting enzyme inhibition in preventing neointima formation. Circulation 1994; 90: 449-455
• 11 Matsuno H, Stassen JM, Hoylaerts MF, Vermylen J, Deckmyn H. Fast and reproducible vascular neointima formation in the hamster carotid artery: effects of trapidil and captopril. Thromb Haemost 1995; 74: 1591-1596
• 12 Matsuno H, Stassen JM, Vermylen J, Deckmyn H. Inhibition of integrin function by a cyclic RGD-containing peptide prevents neointima formation. Circulation 1994; 90: 2203-2206
• 13 Matsuno H, Uematsu T, Nakashima M. Photochemically induced thrombosis model in the rat femoral artery and evaluation of effect of heparin and tissue-type plasminogen activator in this model. J Pharmacol Meth 1991; 25: 303-318
• 14 Powel JS, Glozel JP, Muller RK, Kuhn H, Hefti F, Hosang M, Baumgartner HR. Inhibition of angiotensin-converting enzyme prevents myointimal proliferation after vascular injury. Science 1989; 245: 186-188
• 15 MERCATOR Study Group. Does the new angiotensin converting enzyme inhibitor cilazapril prevent restenosis after percutaneous transluminal coronary angioplasty?. Circulation 1992; 86: 100-110